Page last updated: 2024-11-02

picotamide and Diseases, Peripheral Vascular

picotamide has been researched along with Diseases, Peripheral Vascular in 7 studies

picotamide: has anticoagulant & fibrinolytic properties; structure

Research Excerpts

ExcerptRelevanceReference
"Picotamide treatment caused a decrease of resting thromboxane B2 and endothelin-1 concentrations, produced an improvement of the vascular function as seen by the increase of vascular parameters reported, and attenuated the ischemic treadmill-induced increase of thromboxane B2, but not of endothelin-1."1.30Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease. ( Bonaiuto, M; Campo, GM; Castaldo, M; Cinquegrani, M; D'Arrigo, D; Giordano, G; Imbalzano, E; Saitta, A; Sardo, A; Squadrito, F, 1998)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gresele, P1
Migliacci, R1
Neri Serneri, GG1
Coccheri, S1
Marubini, E1
Violi, F2
Hiatt, WR1
Krantz, MJ1
Hackam, DG1
Neirotti, M1
Molaschi, M1
Ponzetto, M1
Macchione, C1
Poli, L1
Bonino, F1
Fabris, F1
Criqui, M1
Longoni, A1
Castiglioni, C1
Saitta, A1
Sardo, A1
Bonaiuto, M1
Giordano, G1
Imbalzano, E1
Castaldo, M1
Cinquegrani, M1
D'Arrigo, D1
Campo, GM1
Squadrito, F1

Reviews

1 review available for picotamide and Diseases, Peripheral Vascular

ArticleYear
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
    Vascular medicine (London, England), 2006, Volume: 11, Issue:1

    Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Intermittent Claudication;

2006

Trials

3 trials available for picotamide and Diseases, Peripheral Vascular

ArticleYear
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    European heart journal, 2004, Volume: 25, Issue:20

    Topics: Adult; Aged; Aspirin; Diabetic Angiopathies; Double-Blind Method; Female; Follow-Up Studies; Humans;

2004
Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Angiology, 1994, Volume: 45, Issue:2

    Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Coagulation; Blood Viscosity; Double-Blind

1994
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
    Atherosclerosis, 1996, Volume: 120, Issue:1-2

    Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Dis

1996

Other Studies

3 other studies available for picotamide and Diseases, Peripheral Vascular

ArticleYear
Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
    European heart journal, 2004, Volume: 25, Issue:20

    Topics: Arteries; Aspirin; Diabetic Angiopathies; Humans; Peripheral Vascular Diseases; Phthalic Acids; Plat

2004
Medical management of peripheral arterial disease.
    JAMA, 2006, Jul-05, Volume: 296, Issue:1

    Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Peripheral Vascular Diseases; Phthalic Acids; P

2006
Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease.
    Angiology, 1998, Volume: 49, Issue:11

    Topics: Aged; Endothelin-1; Exercise Test; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases;

1998